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Abstract
Perniosis (chilblains) is a vasospastic, inflammatory disease that occurs when the skin is subjected to
cold above the freezing point, under damp conditions. Erythematous (violaceous) blisters, ulcerations
or pustules that sit on an edematous base, accompanied by pain, burning or itching, are usually
evident. To the inexperienced clinician it may resemble community-associated methicillin-resistant
Staphylococcus aureus and could lead to inappropriate treatment. Here we report such a case.
Introduction
Perniosis (chilblains) is a vasospastic, inflammatory
disorder that occurs when the skin of individuals is
unprotected and exposed to a nonfreezing, cold and damp
environment [1]. The discoloration of the extremities and
any accompanying lesions may resemble methicillin-
resistant Staphylococcus aureus (CA-MRSA) [2]. In this era
of heightened awareness regarding CA-MRSA, the unfa-
miliarity of medical practitioners with perniosis may lead
to inappropriate hospital admissions and therapies [3].
Here we report a case of presumed bacterial skin infection
of the feet treated as CA-MRSA when, in fact, it was
perniosis.
Case presentation
A 23-year-old gravida 0, para 0, Caucasian female graduate
student weighing 55 kg and 160 cm in height presented
to her primary care physician with discolored digits
(1 through 3) on both of her feet. She also complained
that her toes were painful, blistered, and intermittently
pruritic. She stated her symptoms had begun the day after
receiving a pedicure before going out to a university event
that same evening. The patient’s vital signs were blood
pressure 120/62 mm Hg, heart rate of 70 beats per minute,
and respirations 14 per minute. Physical examination of
her heart and lungs was unremarkable. Her medical and
surgical histories were negative. She was a non-smoker and
consumed less than 6 ounces of alcohol per week. She had
no allergies. The primary care physician prescribed
cephalexin 500 mg by mouth daily for 10 days for a
presumed bacterial infection.
Ten days later she still complained of discoloration,
blisters and pain, and decided to visit an Emergency
Department (ED) for a second opinion. The ED physician
diagnosed CA-MRSA based on the physical presentations
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the community. Trimethoprim-sulfamethoxazole double
strength (160 mg/800 mg) orally every 12 hours for 10
days was prescribed. The symptoms and signs persisted
and the patient arranged to see a dermatologist, who
performed a biopsy of the third digit (left foot). The
dermatologist declined to prescribe further treatment until
the biopsy returned. The biopsy revealed a histological
diagnosis of perniosis (see Figures 1,2). On further inquiry
by the dermatologist, the patient stated that the evening
after her pedicure she had spent several hours walking
outdoors before the aforementioned university event. She
had worn open-toed shoes and the wind chill factor that
evening had gone as low as 0° F.
The patient was counseled to keep her feet warm and avoid
damp conditions. No other medications were adminis-
tered and the symptoms resolved three weeks later (mid-
April) with conservative care and the return of warmer
ambient temperatures.
Discussion
The prevalence of perniosis in the United States is
u n k n o w n .T h el e s i o n sm a yb es i n g l eo rm u l t i p l e ,
erythematous and usually involve the hand, feet or face
(fingers, toes, nose, or earlobes) [1]. The lesions have also
been found on the hips [4] and thighs [5] of patients. The
lesions of the toes are similar to MRSA and physicians’ lack
of familiarity with perniosis may lead to inappropriate
hospital admissions with expensive evaluations and
hazardous treatments [3].
Differential diagnosis includes systemic lupus erythema-
tosis, cryopathy or connective tissue disease (with loss of
seasonal patterns), polycythemia vera, septic emboli,
Raynaud’s syndrome, atheromatous embolization, pernio
sarcoid, erythromelalgia, vasculitis, peripheral artery dis-
ease, and purple toe syndrome from anticoagulant therapy
[1,3], and now CA-MRSA can be added to this list.
The foremost treatment option requires the use of
appropriate insulated clothing, avoiding immobility,
warm housing, proper exercise and nutrition, and avoid-
ing skin exposure to damp, cold environments [1,3].
Furthermore, nicotine use should be discouraged and
alcohol intake limited [1]. Medication may be used as an
adjunct to the above interventions, and includes nifedi-
pine or amlodipine [1]. These medications increase digital
blood flow, reduce healing time, and lessen pain and
irritation [6-9]. They are prescribed until warm weather
returns and restarted in the autumn as prophylaxis [1].
Ultraviolet light, topical corticosteroids, calcium prepara-
tions, intramuscular vitamin injections, and vasodilators
have been used in the past, but are probably ineffectual
[1,3].
Conclusions
In this report the necessity of a complete history is evident.
The temporal relation of the patient’s pedicure may have
led the initial physicians’ evaluation astray, allowing the
cold exposure to be overlooked. This aspect of the patient’s
interview cannot be overemphasized. Additionally, the
epidemic of CA-MRSA occurring in the United States may
have caused the clinicians to focus on this organism
because of its resistance and virulence, possibly to the
exclusion of other diagnoses. Nonetheless, we encourage
our colleagues to continue to be vigilant in regard to
Figure 1. Hematoxylin and Eosin (40x). This high power view
shows perivascular lymphocytes with intravascular fibrin
indicative of early thrombus formation in our patient.
Figure 2. Perniosis of the toes, example that could be
confusing.
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physicians in the primary care setting to understand and
recognize cold weather injuries.
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